Sarita, Roger .

HRN: 27-96-56  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/18/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
10/18/2025
10/25/2025
IV
2.25g
Q8hr
CAP-HR
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: